State of Wyoming’s Amicus Therapeutics FOLD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-14,237
Closed -$203K 1873
2025
Q4
$203K Buy
14,237
+4,159
+41% +$40.9K 0.02% 962
2025
Q3
$79.4K Buy
10,078
+9,190
+1,035% +$65.4K 0.01% 1381
2025
Q2
$5.09K Buy
+888
New +$5.73K ﹤0.01% 1787
2024
Q2
Sell
-3,193
Closed -$37.6K 1736
2024
Q1
$37.6K Buy
+3,193
New +$40.8K 0.01% 1436
2023
Q3
Sell
-13,049
Closed -$164K 1698
2023
Q2
$164K Buy
13,049
+8,404
+181% +$99.7K 0.05% 511
2023
Q1
$51.5K Sell
4,645
-11,610
-71% -$143K 0.02% 1106
2022
Q4
$198K Buy
+16,255
New +$183K 0.07% 349
2022
Q2
Sell
-38,608
Closed -$365K 1955
2022
Q1
$365K Buy
38,608
+1,622
+4% +$15.2K 0.18% 51
2021
Q4
$427K Buy
36,986
+5,993
+19% +$66.8K 0.2% 49
2021
Q3
$296K Sell
30,993
-1,683
-5% -$17.2K 0.19% 84
2021
Q2
$315K Buy
32,676
+29,711
+1,002% +$290K 0.2% 81
2021
Q1
$29K Buy
+2,965
New +$45.9K 0.05% 279

Other funds holding FOLD

State of Wyoming's FOLD Position: Q1 2026 in Review

State of Wyoming sold out of Amicus Therapeutics (FOLD) in Q1 2026, closing a stake of 14,237 shares — an estimated $203K sold.

State of Wyoming first reported a position in FOLD in Q1 2021 and held it in 12 quarters. The position peaked at $427K in Q4 2021. 298 funds tracked by Wall St. Rank hold FOLD as of Q1 2026.

  • State of Wyoming reported no remaining Amicus Therapeutics position as of Q1 2026 after selling out during the quarter.
  • State of Wyoming sold 14,237 Amicus Therapeutics shares in Q1 2026, an estimated $203K.
  • State of Wyoming first reported a position in Amicus Therapeutics in Q1 2021 and held it in 12 quarters.
  • State of Wyoming's Amicus Therapeutics position peaked at $427K in Q4 2021.
  • 298 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q1 2026.

Based on State of Wyoming's 13F filing for Q1 2026, filed 13 May 2026.